mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
-0.12 |
0.03 |
mRNA |
necrostatin-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.08 |
0.03 |
mRNA |
paclitaxel |
CCLE |
pan-cancer |
AAC |
0.096 |
0.03 |
mRNA |
CCT036477 |
CTRPv2 |
pan-cancer |
AAC |
-0.071 |
0.03 |
mRNA |
XMD11-85h |
GDSC1000 |
pan-cancer |
AAC |
-0.1 |
0.03 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.071 |
0.03 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.073 |
0.03 |
mRNA |
Erlotinib |
CCLE |
pan-cancer |
AAC |
-0.096 |
0.03 |
mRNA |
Bosutinib |
GDSC1000 |
pan-cancer |
AAC |
-0.071 |
0.03 |
mRNA |
lapatinib |
GDSC1000 |
pan-cancer |
AAC |
-0.1 |
0.03 |